Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: April 16, 2008
Event: Entry into a new material definitive credit agreement and termination of a prior agreement.
Key Financial Metrics and Liquidity
- New Credit Facility: $1,200,000,000 five-year unsecured revolving credit agreement.
- Purpose: General corporate purposes and support for commercial paper issuance.
- Interest Rate Options: Base rate (higher of Citibank base rate or 0.5% + federal funds rate) or LIBOR plus an applicable margin based on credit rating and utilization.
- Fees: Quarterly facility fee (varies by rating) and letter of credit/fronting fees.
- Financial Covenants: Consolidated leverage ratio is the only financial covenant.
- Other Metrics: The filing does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes Versus Prior Period
- Termination of Prior Agreement: The Company terminated its existing credit agreement dated December 7, 2004, which was due to mature on December 7, 2010.
- Cost of Termination: No material termination fees or penalties were incurred.
- Lender Relationships: The new agreement involves lenders with pre-existing relationships, including participation in prior credit facilities, share repurchases, bond offerings, and commercial paper programs.
Outlook, Risks, and Contingencies
- Covenants: The agreement includes customary affirmative and negative covenants, including restrictions on liens, consolidations, mergers, and asset sales.
- Events of Default: Includes nonpayment, covenant defaults, breaches of representations, bankruptcy, insolvency, cross defaults, and change of control.
- Management Commentary: The filing focuses on the structural terms of the financing arrangement rather than operational outlook or guidance.
Key Facts for Investor Verification
- Verify the Company's current long-term debt rating to determine the applicable interest rate margin and facility fee under the new agreement.
- Confirm the Company's current consolidated leverage ratio to ensure compliance with the sole financial covenant.
- Review the attached Exhibit 10.1 for the complete text of the Credit Agreement and specific definitions of covenants.
- Monitor the utilization of the $1.2 billion facility to assess liquidity needs and potential impact on commercial paper issuance.